Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance
- 4 August 1992
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 44 (3) , 509-517
- https://doi.org/10.1016/0006-2952(92)90443-m
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Nanoparticles as carriers for growth hormone releasing factorJournal of Controlled Release, 1991
- Multidrug Resistance1JNCI Journal of the National Cancer Institute, 1988
- New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug CarrierDiabetes, 1988
- The cell biology of multiple drug resistanceBiochemical Pharmacology, 1987
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985
- Potentiation of antitumor agents by calcium channel blockers with special reference to cross-resistance patternsCancer Chemotherapy and Pharmacology, 1985
- Tumour cell resistance to anthracyclines ? A reviewCancer Chemotherapy and Pharmacology, 1985
- Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded NanoparticlesJournal of Pharmaceutical Sciences, 1982
- Solid colloidal drug delivery systems: NanoparticlesInternational Journal of Pharmaceutics, 1981
- Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive propertiesJournal of Pharmacy and Pharmacology, 1979